BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dote S, Itakura S, Kamei K, Hira D, Noda S, Kobayashi Y, Terada T. Oral mucositis associated with anti-EGFR therapy in colorectal cancer: single institutional retrospective cohort study. BMC Cancer 2018;18:957. [PMID: 30290786 DOI: 10.1186/s12885-018-4862-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Choi YJ, Choi C, Rhie SJ, Shin S. Safety Assessment on Serious Adverse Events of Targeted Therapeutic Agents Prescribed for RAS Wild-Type Metastatic Colorectal Cancer: Systematic Review and Network Meta-Analysis. IJERPH 2022;19:9196. [DOI: 10.3390/ijerph19159196] [Reference Citation Analysis]
2 Wang Y, Zhao M, Zhao H, Cheng S, Bai R, Song M. MicroRNA-940 restricts the expression of metastasis-associated gene MACC1 and enhances the antitumor effect of Anlotinib on colorectal cancer. Onco Targets Ther 2019;12:2809-22. [PMID: 31114229 DOI: 10.2147/OTT.S195364] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]